2022-11-012023-10-312023-10-31false12240748OPES HEALTH LTD2024-04-1186900iso4217:GBPxbrli:pure122407482022-11-01122407482023-10-31122407482022-11-012023-10-31122407482021-11-01122407482022-10-31122407482021-11-012022-10-3112240748bus:SmallEntities2022-11-012023-10-3112240748bus:AuditExempt-NoAccountantsReport2022-11-012023-10-3112240748bus:FullAccounts2022-11-012023-10-3112240748bus:PrivateLimitedCompanyLtd2022-11-012023-10-3112240748core:WithinOneYear2023-10-3112240748core:AfterOneYear2023-10-3112240748core:WithinOneYear2022-10-3112240748core:AfterOneYear2022-10-3112240748core:ShareCapital2023-10-3112240748core:SharePremium2023-10-3112240748core:RevaluationReserve2023-10-3112240748core:OtherReservesSubtotal2023-10-3112240748core:RetainedEarningsAccumulatedLosses2023-10-3112240748core:ShareCapital2022-10-3112240748core:SharePremium2022-10-3112240748core:RevaluationReserve2022-10-3112240748core:OtherReservesSubtotal2022-10-3112240748core:RetainedEarningsAccumulatedLosses2022-10-3112240748core:LandBuildings2023-10-3112240748core:PlantMachinery2023-10-3112240748core:Vehicles2023-10-3112240748core:FurnitureFittings2023-10-3112240748core:OfficeEquipment2023-10-3112240748core:NetGoodwill2023-10-3112240748core:IntangibleAssetsOtherThanGoodwill2023-10-3112240748core:ListedExchangeTraded2023-10-3112240748core:UnlistedNon-exchangeTraded2023-10-3112240748core:LandBuildings2022-10-3112240748core:PlantMachinery2022-10-3112240748core:Vehicles2022-10-3112240748core:FurnitureFittings2022-10-3112240748core:OfficeEquipment2022-10-3112240748core:NetGoodwill2022-10-3112240748core:IntangibleAssetsOtherThanGoodwill2022-10-3112240748core:ListedExchangeTraded2022-10-3112240748core:UnlistedNon-exchangeTraded2022-10-3112240748core:LandBuildings2022-11-012023-10-3112240748core:PlantMachinery2022-11-012023-10-3112240748core:Vehicles2022-11-012023-10-3112240748core:FurnitureFittings2022-11-012023-10-3112240748core:OfficeEquipment2022-11-012023-10-3112240748core:NetGoodwill2022-11-012023-10-3112240748core:IntangibleAssetsOtherThanGoodwill2022-11-012023-10-3112240748core:ListedExchangeTraded2022-11-012023-10-3112240748core:UnlistedNon-exchangeTraded2022-11-012023-10-3112240748core:MoreThanFiveYears2022-11-012023-10-3112240748core:Non-currentFinancialInstruments2023-10-3112240748core:Non-currentFinancialInstruments2022-10-3112240748dpl:CostSales2022-11-012023-10-3112240748dpl:DistributionCosts2022-11-012023-10-3112240748core:LandBuildings2022-11-012023-10-3112240748core:PlantMachinery2022-11-012023-10-3112240748core:Vehicles2022-11-012023-10-3112240748core:FurnitureFittings2022-11-012023-10-3112240748core:OfficeEquipment2022-11-012023-10-3112240748dpl:AdministrativeExpenses2022-11-012023-10-3112240748core:NetGoodwill2022-11-012023-10-3112240748core:IntangibleAssetsOtherThanGoodwill2022-11-012023-10-3112240748dpl:GroupUndertakings2022-11-012023-10-3112240748dpl:ParticipatingInterests2022-11-012023-10-3112240748dpl:GroupUndertakingscore:ListedExchangeTraded2022-11-012023-10-3112240748core:ListedExchangeTraded2022-11-012023-10-3112240748dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-11-012023-10-3112240748core:UnlistedNon-exchangeTraded2022-11-012023-10-3112240748dpl:CostSales2021-11-012022-10-3112240748dpl:DistributionCosts2021-11-012022-10-3112240748core:LandBuildings2021-11-012022-10-3112240748core:PlantMachinery2021-11-012022-10-3112240748core:Vehicles2021-11-012022-10-3112240748core:FurnitureFittings2021-11-012022-10-3112240748core:OfficeEquipment2021-11-012022-10-3112240748dpl:AdministrativeExpenses2021-11-012022-10-3112240748core:NetGoodwill2021-11-012022-10-3112240748core:IntangibleAssetsOtherThanGoodwill2021-11-012022-10-3112240748dpl:GroupUndertakings2021-11-012022-10-3112240748dpl:ParticipatingInterests2021-11-012022-10-3112240748dpl:GroupUndertakingscore:ListedExchangeTraded2021-11-012022-10-3112240748core:ListedExchangeTraded2021-11-012022-10-3112240748dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-11-012022-10-3112240748core:UnlistedNon-exchangeTraded2021-11-012022-10-3112240748core:NetGoodwill2023-10-3112240748core:IntangibleAssetsOtherThanGoodwill2023-10-3112240748core:LandBuildings2023-10-3112240748core:PlantMachinery2023-10-3112240748core:Vehicles2023-10-3112240748core:FurnitureFittings2023-10-3112240748core:OfficeEquipment2023-10-3112240748core:AfterOneYear2023-10-3112240748core:WithinOneYear2023-10-3112240748core:ListedExchangeTraded2023-10-3112240748core:UnlistedNon-exchangeTraded2023-10-3112240748core:ShareCapital2023-10-3112240748core:SharePremium2023-10-3112240748core:RevaluationReserve2023-10-3112240748core:OtherReservesSubtotal2023-10-3112240748core:RetainedEarningsAccumulatedLosses2023-10-3112240748core:NetGoodwill2022-10-3112240748core:IntangibleAssetsOtherThanGoodwill2022-10-3112240748core:LandBuildings2022-10-3112240748core:PlantMachinery2022-10-3112240748core:Vehicles2022-10-3112240748core:FurnitureFittings2022-10-3112240748core:OfficeEquipment2022-10-3112240748core:AfterOneYear2022-10-3112240748core:WithinOneYear2022-10-3112240748core:ListedExchangeTraded2022-10-3112240748core:UnlistedNon-exchangeTraded2022-10-3112240748core:ShareCapital2022-10-3112240748core:SharePremium2022-10-3112240748core:RevaluationReserve2022-10-3112240748core:OtherReservesSubtotal2022-10-3112240748core:RetainedEarningsAccumulatedLosses2022-10-3112240748core:NetGoodwill2021-11-0112240748core:IntangibleAssetsOtherThanGoodwill2021-11-0112240748core:LandBuildings2021-11-0112240748core:PlantMachinery2021-11-0112240748core:Vehicles2021-11-0112240748core:FurnitureFittings2021-11-0112240748core:OfficeEquipment2021-11-0112240748core:AfterOneYear2021-11-0112240748core:WithinOneYear2021-11-0112240748core:ListedExchangeTraded2021-11-0112240748core:UnlistedNon-exchangeTraded2021-11-0112240748core:ShareCapital2021-11-0112240748core:SharePremium2021-11-0112240748core:RevaluationReserve2021-11-0112240748core:OtherReservesSubtotal2021-11-0112240748core:RetainedEarningsAccumulatedLosses2021-11-0112240748core:AfterOneYear2022-11-012023-10-3112240748core:WithinOneYear2022-11-012023-10-3112240748core:Non-currentFinancialInstrumentscore:CostValuation2022-11-012023-10-3112240748core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-11-012023-10-3112240748core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-11-012023-10-3112240748core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-11-012023-10-3112240748core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-11-012023-10-3112240748core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-11-012023-10-3112240748core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-11-012023-10-3112240748core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-11-012023-10-3112240748core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-11-012023-10-3112240748core:Non-currentFinancialInstrumentscore:CostValuation2023-10-3112240748core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-10-3112240748core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-10-3112240748core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-10-3112240748core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-10-3112240748core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-10-3112240748core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-10-3112240748core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-10-3112240748core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-10-3112240748core:Non-currentFinancialInstrumentscore:CostValuation2022-10-3112240748core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-10-3112240748core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-10-3112240748core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-10-3112240748core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-10-3112240748core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-10-3112240748core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-10-3112240748core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-10-3112240748core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-10-3112240748bus:Director12022-11-012023-10-31

OPES HEALTH LTD

Registered Number
12240748
(England and Wales)

Unaudited Financial Statements for the Year ended
31 October 2023

OPES HEALTH LTD
Company Information
for the year from 1 November 2022 to 31 October 2023

Director

WOOTON, Julie

Registered Address

Alderwood
Durham Road
Wingate
TS28 5HP

Registered Number

12240748 (England and Wales)
OPES HEALTH LTD
Balance Sheet as at
31 October 2023

Notes

2023

2022

£

£

£

£

Current assets
Debtors127,00481,330
Cash at bank and on hand4,902902
131,90682,232
Creditors amounts falling due within one year4(43,935)(25,599)
Net current assets (liabilities)87,97156,633
Total assets less current liabilities87,97156,633
Net assets87,97156,633
Capital and reserves
Called up share capital11
Profit and loss account87,97056,632
Shareholders' funds87,97156,633
The financial statements were approved and authorised for issue by the Director on 11 April 2024, and are signed on its behalf by:
WOOTON, Julie
Director
Registered Company No. 12240748
OPES HEALTH LTD
Notes to the Financial Statements
for the year ended 31 October 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
2.Average number of employees

20232022
Average number of employees during the year00
3.Tangible fixed assets
4.Creditors: amounts due within one year

2023

2022

££
Trade creditors / trade payables377714
Bank borrowings and overdrafts4,3315,714
Taxation and social security39,22219,171
Other creditors5-
Total43,93525,599
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.